Xponance’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Xponance’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,624	Closed	-$247K	–	1258
2022 Q3	$247K	Buy	+3,624	New	+$200K	﹤0.01%	1048
2021 Q2	–	Sell	-6,263	Closed	-$255K	–	1266
2021 Q1	$255K	Buy	6,263 +232	+4%	+$10.7K	0.01%	991
2020 Q4	$261K	Sell	6,031 -36	-0.6%	-$1.77K	0.01%	986
2020 Q3	$335K	Buy	6,067 +21	+0.3%	+$1.33K	0.01%	815
2020 Q2	$382K	Buy	+6,046	New	+$415K	0.01%	736

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's GBT Position: Q4 2022 in Review

Xponance sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,624 shares — an estimated $247K sold.

Xponance first reported a position in GBT in Q2 2020 and held it in 5 quarters. The position peaked at $382K in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Xponance reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Xponance sold 3,624 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $247K.
Xponance first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 5 quarters.
Xponance's Global Blood Therapeutics, Inc. position peaked at $382K in Q2 2020.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.